Mesenchymal Stromal Cell Therapy in Renal Recipients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This study will test the hypothesis that MSCs in combination with Everolimus facilitate Tacrolimus withdrawal, reduce fibrosis and decrease the incidence of opportunistic infections compared to standard tacrolimus dose.
Epistemonikos ID: dc1412ca1a82cb57cab981fb7035e4ffca389315
First added on: May 11, 2024